CRISPR Therapeutics AG - NAMEN AKT (CRSP)

Q1 2021 13F Portfolio Holders as of 3/31/2021

Type / Class
Equity / NAMEN AKT
Number of holders
432
Total Shares
42.6M
Shares change
-4.45M
Total reported value, excl. options
$5.2B
Value change
-$577M
Put/Call ratio
1.19
Number of buys
268
Number of sells
-159
Price
$121.85
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.